Avoiding allogenic blood transfusions in endoscopic angiofibroma surgery by Hisham Wasl et al.
ORIGINAL RESEARCH ARTICLE Open Access
Avoiding allogenic blood transfusions in
endoscopic angiofibroma surgery
Hisham Wasl*, Jessica McGuire and Darlene Lubbe
Abstract
Background: Surgical approaches for many tumours are often limited by blood loss, exposure and risk to vital
anatomical structures. Therefore, the standard of care for certain skull base tumours has become endoscopic transnasal
resection. Other surgical disciplines often use cell salvage techniques, but review of the otolaryngology literature revealed
very few case reports. This study investigated the value and safety of salvage-type autologous blood transfusion during
the endoscopic resection of juvenile nasopharyngeal angiofibromas (JNA).
Methods: JNA is a rare vascular nasal tumour and the study extended over a 3-year period to obtain adequate
patient numbers. All patients undergoing endoscopic resection during this period were included in the
population sample. Ten patients with JNA were identified and underwent embolization prior to the endoscopic
resection. In all cases the intraoperative blood salvage apparatus was used. Close post-operative monitoring was
performed.
Results: Homologous blood transfusion could be avoided in all cases. Postoperative monitoring revealed transient
bacteraemia in two cases where the leukocyte filter was not used, but no evidence of septicaemia.
Conclusions: Perioperative cell saver and autologous blood transfusion in endonasal JNA surgery is safe. Homologous
blood transfusion can be avoided by using this technique. The use of cell salvage allows for single stage surgery
without the need to abandon surgery due to excessive blood loss and its future use is promising.
Background
For more than 25 years, trauma, orthopaedic, urological,
liver transplant and cardiac surgery have used intraopera-
tive cell salvage (ICS) techniques [1]. However, in contami-
nated surgical fields the role of cell salvage techniques has
been contentious. Contaminated surgical fields have been
previously considered as a relative or absolute contraindi-
cation for intraoperative cell salvage. However, it is in-
creasingly being used during trauma surgery even though
the surgical field is often deemed contaminated and has
been found to be a safe technique. A review of the litera-
ture reveals no research about the utilisation of cell salvage
techniques in endonasal surgery.
Haemorrhage during tumour surgery often results in
the need for intraoperative allogeneic blood transfusion.
Many reports have focused on allogenic transfusion risks,
such as immunomodulation, transfusion related immune-
mediated reactions and infection. It may be associated
with increased mortality, myocardial infarction and in-
creased risk of tumour recurrence [2]. ICS autologous
blood transfusions reduce the need for allogenic blood
transfusions.
Other advantages of ICS autologous blood transfusions
are reduced burden on blood donation systems, the
blood available is proportional to the blood lost during
surgery, there is no haemodilution; and it can be used
when significant blood loss is anticipated [3]. Salvaged
red cells also have a better oxygen delivery profile, and
the system is cost-effective.
Pre-operative embolization is associated with less
blood loss. A meta-analysis of the clinical features and
treatment outcomes were unable to draw definitive con-
clusions regarding expected blood loss because most
studies do not stratify blood loss according to stage and
most studies on JNA are non-comparative case series
[4]. At our institute almost all patients with Fisch stage
2c and 3 would require a transfusion, even with pre-
operative embolization.* Correspondence: hisham7070@yahoo.com
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The autologous red cell recovery system, also known as
the “cell saver”, has a double lumen tube that mixes the
aspirated blood with a heparin solution and collects it in a
reservoir (Fig. 1). A centrifuge is then used to separate
erythrocytes from the blood and cell stroma, free haemo-
globin and plasma flow to the waste bag. The leukocyte
filter is used to provide further protection, and blood is
then re-infused into the patient (Fig. 1). The mechanisms
of leukocyte reduction by leukocyte depletion filter (LDF)
are insufficiently understood. It is widely accepted that
centrifugal effects are used to eliminate bacteria with cell
saver methods. Bacterial removal mechanisms of the
leukocyte depletion filter (LDF) cannot depend on the size
of bacteria alone and may be more dependent on adhesive
characteristics of the filter, such as the surface structure of
the material used in the filter, wettability, surface charge,
the disintegration of cells, and deformability of infected
cells in the filter [5, 6]. Reports indicate that 97.6 to 100 %
of bacterial colony-forming units may be cleared when blood
is subjected to a leukocyte filtration system and is washed.
According to our reading, there has been no research
done with regards to the role of red cell salvage in endo-
scopic JNA surgery. This research forms a preliminary
study into the role of cell salvage during JNA surgery.
Methods
We conducted a prospective study over a 3 year period of
all patients undergoing endoscopic resection of JNA at 2
centres, by a single surgeon. Ten patients were enrolled,
they all had Fisch stage 3 or 4 tumours and all underwent
pre-operative embolization, had intra-operative cell sal-
vage and close postoperative monitoring. We received eth-
ics approval from the Human Research Ethics Committee
of the University of Cape Town. Inclusion criteria were an
estimated blood loss of more than 500 ml and a patient
that may qualify for an intraoperative blood transfusion.
No JNA patients were excluded.
Patients were all male and aged between 12 and 20 years.
The first patient was a Jehovah’s Witness and refused allo-
geneic blood transfusion; however the church found autolo-
gous blood transfusion via a salvage system acceptable if
transfusion was required. No leucocyte filter was available
in the government sector hospital and the surgeons advised
against surgery since the transfusion likelihood was 100 %
for a stage 2c tumour at our institution. However, due to
state policy the surgeons were obligated to perform surgery.
The Fisch staging system for JNA grades tumours invad-
ing pterygomaxillary fossa and paranasal sinuses with bony
destruction as stage 2. Stage 3 tumours invade the infra-
temporal fossa, orbit and/or parasellar region, remaining
lateral to cavernous sinus (Fig. 2).
Based on the Fisch staging system for JNA, 6 patients
had stage 2 tumours and 4 had stage 3 tumours (Table 1).
Two patients with stage 3 disease had staged procedures
with initial incomplete resection and the rest of the pa-
tient had successful complete resection of the tumour at
the first surgery. Of the 2 patients requiring a second stage
procedure, 1 had unsuccessful preoperative embolization
and the first surgery was terminated as a result of bleeding
and the other patient had extensive disease and residual
tumour which required a second look procedure.
An intra-operative nasal swab was taken to determine
the presence of bacteria in the surgical field and to ob-
tain sensitivities in the event that antibiotics were re-
quired postoperatively. The cell saver system was used
to salvage autologous blood. A second specimen for mi-
croscopy, culture and sensitivity (MCS) was taken from
the cell saver system to detect the presence of organisms
in the autologous blood that was to be transfused back
to the patient.
Fig. 1 Cell salvage techniques
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The anaesthetist and surgeon based decisions to trans-
fuse each patient on their haemoglobin and clinical
stability. The transfusion trigger was a haemoglobin of
7.0 g/dL or a falling pH level or an increasing anion gap.
Blood was collected from the cell saver unit by a techni-
cian. Heparin was added to the collected blood, and only
processed if a sufficient volume was recovered, or if the
patient required a blood transfusion based on the above
parameters. The disposables and the leukocyte filter need
only be set up when a decision to process the blood is
made. We found that using this standby technique could
reduce the costs of cell salvage by 90 % if no blood was
processed. This is important in resource-restricted
hospitals.
The leukocyte filter was not used in two cases, as it
was not available in the state hospital at that time. The
rationale for proceeding with the autologous blood
transfusion was that the patients were covered with
broad spectrum antibiotics and the surgical site, al-
though colonised by bacteria, was not infected. United
Kingdom guidelines for autologous intraoperative blood
transfusion recommend the use of a LDF in surgery for
malignant disease, although they state that extensive
clinical experience suggests the risk of seeding is not
significant. JNA are benign tumours with no risk of
distant metastases [7].
Our decision to use the LDF was based on knowledge
that the nasal cavity is colonised by bacteria. There are
no specific guidelines for the use of LDF in uncontamin-
ated, colonised surgical fields [7].
All patients received prophylactic intraoperative antibi-
otics and a post-operative course of broad spectrum anti-
biotics for 48 h. Patients were monitored for signs of
infection/ septicaemia by routine methods of temperature
and pulse rate. A blood culture was performed 1 day
following surgery to exclude a bacteraemia or septicaemia.
Postoperatively, all patients were admitted to the
intensive care unit (ICU) for one day for monitoring.
Laboratory coagulation tests were taken on admission to
ICU, and the international normalised ratio (INR) in the
laboratory control group was 1.1.
The mean hospital stay for all patients was 3 days. Nasal
packs were removed on the second day after surgery and
no patients needed a relook procedure for haemostasis.
All patients were seen in the clinic 7 days after surgery for
routine endoscopic examination and nasal debridement.
They had post-operative magnetic resonance imaging
3 months post-surgery and after 6 months; yearly
follow up was planned for all patients.











Patient 1 12 2 500 ml 200 ml Staphylococcus Aureus No growth No growth
Patient 2 19 2 500 ml 300 ml Staphylococcus Aureus No growth No growth
Patient 3 18 3 1700 ml 700 ml Staphylococcus Aureus No growth No growth






16 3 4000 ml 2500 ml Streptococcus Viridans No growth No growth
Patient 6 14 3 3000 ml 1700 ml Methicillinresistant Staphylococcus
Aureus (MRSA)
No growth No growth
Patient 7 15 2 1000 ml 600 ml Staphylococcus Epidermidis No growth No growth
Patient 8 13 2 900 ml 400 ml Streptococcus Viridans No growth No growth
Patient 9 16 2 1000 ml 600 ml Moraxella Catarrhalis No growth No growth




Fig. 2 Computed tomography scan showing a Fisch stage 3 JNA
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Results
The mean volume of blood lost from the 10 patients
was 1530 mL (500–4000 mL). The mean volume of re-
infused blood was 875 mL (200–2600 mL) (Table 1).
Bacterial growth was detected on all nasal swabs. Or-
ganisms that were cultured included: Staphylococcus aur-
eus, Staphylococcus epidermidis, Streptococcus viridans,
and Moreaxella catarrhalis (Table 1).
In both cases in which a LDF was not available, the
same organism that was isolated from the nasal cavity
was also cultured from the cell saver washed blood.
Postoperatively the 2 patients developed a transient bac-
teraemia with a raised temperature and pulse rate and a
positive blood culture, in which the same organism was
grown (Table 1). Both were treated with the appropriate
intravenous antibiotics according to sensitivities and
both recovered completely.
Routine postoperative monitoring revealed that haemo-
globin and coagulation levels were within the normal
range for all patients, with no evidence of major complica-
tions such as haemoglobinuria, coagulopathy, cardio-
pulmonary issues or sepsis. None of the patients had
postoperative epistaxis. None of the patients required
any allogeneic blood products. Regular follow up after
discharge showed no adverse events (minimum follow-
up time was 18 months).
Discussion and conclusions
The most common benign vascular neoplasm of the naso-
pharynx is juvenile angiofibroma (JNA) [5]. It is locally de-
structive and causes bony erosion despite its benign
histology. JNA can extend intracranially and cause compli-
cations that are potentially life threatening, such as
massive blood loss and fatal epistaxis [5]. There are both
fibrotic and vascular elements within the tumours, but the
vessels lack an elastic lamina and this precludes constric-
tion and is partially responsible for their propensity to
bleed [6, 8]. The management of JNA can be challenging
because of its aggressive growth pattern, vital adjacent
anatomical structures and rich blood supply.
Our institute uses two methods to control blood loss
during JNA surgery: the first method is preoperative
embolization which was performed in all our patients. The
second method is intraoperative cell salvage technique.
Our greatest concern was that we were re-infusing
blood from a bacterially colonised surgical field. This
has been done previously in gastrointestinal surgery for
perforated peptic ulcers. They covered the patients with
broad spectrum antibiotics perioperatively and the only
post-operative complication they had were wound infec-
tions in 3 out of 11 patients, which may have been unre-
lated to the transfusion [9]. This was reinforced by a
study of patients undergoing liver transplantation who
received ICS blood transfusion and despite there being
positive bacterial cultures in 8 out of 28 re-transfusion
bags, no post-operative infections were observed. The
patients’ blood cultures remained negative 1 week post-
surgery [10]. Other surgical disciplines have also demon-
strated the successful use of culture-positive cell saver
blood with no reported adverse clinical consequences
[11-13]. Another concern associated with cell salvage
blood is the promotion of coagulopathy, but no evidence
of coagulopathy was revealed in any of our patients, and
all laboratory parameters were normal.
The use of cell salvage autologous blood transfusion is
cost effective and reduces the need for allogenic transfu-
sions. This is associated with shorter hospital stays, reduced
blood transfusion reactions and reduced postoperative in-
fection rates. The cost of leukocyte filters should be a con-
sideration, especially in resource limited settings. Although
these filters are not expensive; additional savings may be in-
stituted by employing a standby technique in JNA surgery,
which includes collecting blood from the operative field but
only using it if necessary.
The combination of washing blood cells and using a
leucocyte filter significantly reduced the bacterial load in
processed blood that could then be safely re-transfused
to the patient. Leukocyte depletion filters have been
widely used during the processing of donated blood to
remove white blood cells and their use is now acknowl-
edged to improve cell salvage safety and to reduce the
incidence of any cell salvage adverse effects [14]. Various
findings have revealed that leukocyte depletion filters are
effective in removing white blood cells, tumour cells
[15–17], amniotic fluid [18], and bacteria [3].
Our study has shown that cell saver techniques are
beneficial in JNA surgery, as the surgery can be com-
pleted in a single stage, there is a decreased need for
allogenic blood transfusion, and it is often acceptable to
Jehovah’s Witness patients. This study has also demon-
strated that intraoperative cell salvage is a safe technique in
endoscopic JNA surgery. We recommend the use of leuco-
cyte depletion filters and perioperative broad-spectrum an-
tibiotics. Our findings indicate that the commensal bacteria
that are introduced with the re-transfused blood are suc-
cessfully eliminated by an intact immunological system.
This explains the good tolerance to the iatrogenic bacter-
aemia that was caused.
In conclusion, cell salvage autologous blood transfusion
is safe and effective in reducing allogenic blood transfu-
sion requirements in endoscopic JNA surgery. Cell salvage
should be considered in all cases of JNA surgery as signifi-
cant blood loss is usually anticipated. This can also be
used in situations when patients refuse allogenic blood
products. The standby technique allows cell salvage to be
used in cases where blood transfusion is not required,
but significant bleeding is a possibility, which contrib-
utes to relieving the stress on blood donation services.
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Leukocyte depletion filters are recommended to pro-
vide an additional element of safety, and should be used
in all cell salvage autologous blood transfusions. In addition,
a contaminated surgical field is not a contraindication for
the use of cell salvage blood as long as adequate pre-
cautions are taken. Recent evidence has shown that cell
salvage may be used in malignancy surgery, and that the
only contraindication to using cell salvage blood, is the
patient’s refusal to accept autologous blood.
A limitation of our study is the small number of patients
due to the rarity of the disease. Further research is needed
with a larger population sample to define the efficacy of
this technique in avoiding allogeneic blood transfusions
and its impact on several outcome variables.
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